Please assess the completion status of the following clinical trial:

Trial Title: Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who have signed a General Consent form approving use of their residual blood samples for research purposes (applicable at CHUV only)~* Patients who have signed a consent allowing the use of their residual sample (Restprobenerklärung) (applicable at MUI, only)~* Patients over the age of 18 years (\>18)~* Patients with bacteremia considered to be due to E. coli or K. pneumoniae~* Patients whose positive blood cultures were not older than 24 hours at the time of AST start~Exclusion Criteria:~* Patients with documented refusal of the use of biological material for research purposes (applicable at CHUV, only)~* Patients with polymicrobial bacteremia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).